(Total Views: 297)
Posted On: 11/15/2020 11:37:36 PM
Post# of 36564
I don’t want to get in the middle of you two guys debate, but obviously Covid had an effect on all trial recruitment:
https://www.clinicaltrialsarena.com/comment/c...ons-covid/
For AE37/ Keytruda the info is publicly stated in the new NGIO 10k:
“The Phase II trial began enrolling patients in September of 2019, and is expected to enroll 29 patients. The SARS-CoV-2 epidemic temporarily paused enrollment for the first half of the year, however, patient screening has restarted and enrollment is continuing.”
https://www.sec.gov/Archives/edgar/data/18045...-index.htm
https://www.clinicaltrialsarena.com/comment/c...ons-covid/
For AE37/ Keytruda the info is publicly stated in the new NGIO 10k:
“The Phase II trial began enrolling patients in September of 2019, and is expected to enroll 29 patients. The SARS-CoV-2 epidemic temporarily paused enrollment for the first half of the year, however, patient screening has restarted and enrollment is continuing.”
https://www.sec.gov/Archives/edgar/data/18045...-index.htm
(0)
(0)
